earnings
GA
NASDAQ · GANX
Gain Therapeutics, Inc.
Healthcare · Biotechnology
$1.72
Up+$0.06 (+3.49%)
Updated Sep 17, 2026, 8:38 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 148.53M
- P/E ratio
- -6.72
- Dividend yield
- 0.00%
- 52-week range
- $1.53 – $3.07
- Volume
- 265.93K
- Avg. volume
- 1.01M
Price performance
GANX price history
1M range · 20 trading sessions · Daily adjusted prices
GANX closed at $1.72 after 20 trading sessions, down 16.91% for the selected period.
- Last close
- $1.72
- Period change
- -16.91%
- Period low
- $1.71
- Period high
- $2.07
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.73 | $1.7895 | $1.70 | $1.72 | 265.93K |
| Sep 15, 2026 | $1.74 | $1.74 | $1.69 | $1.71 | 215.69K |
| Sep 14, 2026 | $1.76 | $1.80 | $1.73 | $1.74 | 360.12K |
| Sep 11, 2026 | $1.748 | $1.78 | $1.72 | $1.75 | 223.56K |
| Sep 10, 2026 | $1.72 | $1.74 | $1.69 | $1.71 | 505.65K |
| Sep 9, 2026 | $1.81 | $1.83 | $1.72 | $1.72 | 513.39K |
| Sep 8, 2026 | $1.80 | $1.85 | $1.77 | $1.83 | 292.34K |
| Sep 4, 2026 | $1.81 | $1.83 | $1.785 | $1.80 | 205.35K |
| Sep 3, 2026 | $1.80 | $1.825 | $1.77 | $1.82 | 391.41K |
| Sep 2, 2026 | $1.78 | $1.846 | $1.75 | $1.79 | 367.69K |
| Sep 1, 2026 | $1.83 | $1.83 | $1.77 | $1.77 | 197.91K |
| Aug 31, 2026 | $1.77 | $1.84 | $1.76 | $1.80 | 259.89K |
| Aug 28, 2026 | $1.84 | $1.855 | $1.76 | $1.77 | 312.53K |
| Aug 27, 2026 | $1.85 | $1.90 | $1.795 | $1.85 | 416.11K |
| Aug 26, 2026 | $1.91 | $1.92 | $1.80 | $1.81 | 723.42K |
| Aug 25, 2026 | $2.00 | $2.05 | $1.90 | $1.905 | 383.52K |
| Aug 24, 2026 | $2.01 | $2.03 | $1.93 | $2.00 | 315.9K |
| Aug 21, 2026 | $2.00 | $2.045 | $1.98 | $2.005 | 277.48K |
| Aug 20, 2026 | $2.03 | $2.035 | $1.95 | $1.98 | 382.53K |
| Aug 19, 2026 | $2.02 | $2.085 | $2.02 | $2.07 | 300.04K |
Latest GANX news
The latest Smart Investors Daily articles mentioning GANX.
Stock researchResearch & News · SEC Filings
Loading stock research…